http://anthonydwilliams.com/2007/02/28/a-wikinomics-approach-to-rd/ Thu, 15 Mar 2012 10:06:44 +0000 hourly 1 http://wordpress.org/?v=3.0.1 http://anthonydwilliams.com/2007/02/28/a-wikinomics-approach-to-rd/comment-page-1/#comment-35832 Wikinomics» Blog Archive » GlaxoSmithKlein pledges patent pool for neglected diseases Mon, 16 Feb 2009 05:17:34 +0000 http://anthonydwilliams.com/2007/02/28/a-wikinomics-approach-to-rd/#comment-35832 [...] time ago, I reported that Novartis had adopted a wikinomics approach to its diabetes research. After investing millions of dollars trying to unlock the genetic basis of type 2 diabetes, the [...] [...] time ago, I reported that Novartis had adopted a wikinomics approach to its diabetes research. After investing millions of dollars trying to unlock the genetic basis of type 2 diabetes, the [...]

]]> http://anthonydwilliams.com/2007/02/28/a-wikinomics-approach-to-rd/comment-page-1/#comment-35831 GlaxoSmithKlein pledges patent pool for neglected diseases | Anthony D. Williams Mon, 16 Feb 2009 05:12:48 +0000 http://anthonydwilliams.com/2007/02/28/a-wikinomics-approach-to-rd/#comment-35831 [...] time ago, I reported that Novartis had adopted a wikinomics approach to its diabetes research. After investing millions of dollars trying to unlock the genetic basis of type 2 diabetes, the [...] [...] time ago, I reported that Novartis had adopted a wikinomics approach to its diabetes research. After investing millions of dollars trying to unlock the genetic basis of type 2 diabetes, the [...]

]]>